Personal websites

  1. Home
  2. Scientific publications

Scientific publications

COMPLETE LIST OF PUBLICATIONS IN: 

Scientific name of Laura Orío Ortiz: Orio, L

PUBMED: 

 https://pubmed.ncbi.nlm.nih.gov/?term=Laura+Orio&sort=date

ORCID: 0000-0002-9614-4062  

https://orcid.org/0000-0002-9614-4062

ResearcherID: F-4827-2016

https://publons.com/researcher/1342282/laura-orio/

SCOPUS: 6506160890

Google Scholar: 29-O87KAAAAJ

UCM bibliometric portal:

https://bibliometria.ucm.es/fichaInvestigador/dp/12299

ResearchGate:

 https://www.researchgate.net/profile/Laura_Orio2

HIGHLIGHTED PUBLICATIONS:

IF: Impact factors in the year of publication or closer (#) available. Ranking in the area: Q1: first quartile; D1: first decile.

IN THE FIELD OF NEUROINFLAMMATION AND ALCOHOL ABUSE

  • Escudero, B; Moya, M; López-Valencia, L; Arias,F; Orio, L* (2023) Reelin plasma levels identify cognitive decline in Alcohol Use Disorder subjects during early abstinence: the influence of APOE4 expression". International Journal of Neuropsychopharmacology 26(8):545-556 *corresponding autor  IF:5.67 Ranking: Q1
  • Moya M, Escudero B, Gómez-Blázquez E, Rebolledo-Poves AB, López-Gallardo M, Guerrero C, Marco EM and Orio L* (2022) Upregulation of TLR4/MyD88 pathway in alcohol-induced Wernicke's encephalopathy: findings in preclinical models and in a postmortem human case. Frontiers in Pharmacology 13:866574 *corresponding author. IF: 5.6 Ranking: Q1
  • Orio L*, Arias F, Escudero B (2022)  A case of Wernicke's Encephalopathy that maintains long-term cognitive deterioration but not inflammation in spite of thiamine supplementation. Psychiatry & Clinical Neurosciences 76: 475-4. *corresponding author. IF=11.9 Ranking: Q1 (D1)

  • Moya M, López-Valencia L, García-Bueno B, Orio L* (2022). Disinhibition-Like Behavior Correlates with Frontal Cortex Damage in an Animal Model of Chronic Alcohol Consumption and Thiamine Deficiency. Biomedicines,10(2):260. *corresponding author. 

    IF=6.08 Ranking: Q1
  • Rodríguez-González A, Vitali F, Moya M, De Filippo C, Passani MB, Orio L* (2021) Effects of Alcohol Binge Drinking and Oleoylethanolamide Pretreatment in the Gut Microbiota. Front Cell Infect Microbiol. 11:731910 *corresponding author. IF=5.29 Ranking: Q1

  • Moya M, San Felipe D, Ballesta A, Alén F, Rodríguez de Fonseca F, García-Bueno B, Marco EM, Orio L. (2021) Cerebellar and cortical TLR4 activation and behavioral impairments in Wernicke-Korsakoff Syndrome: Pharmacological effects of oleoylethanolamide.

    Prog Neuropsychopharmacol Biol Psychiatry 108:110190 

    *corresponding author. IF=5.07 Ranking:Q1
  • Ballesta A, Alen F, Orio L, Arco R, Vadas E, Decara J, Vargas A, Gómez de Heras R, Ramírez-López M, Serrano A, Pavón FJ, Suárez J, Rodríguez de Fonseca F(2020) Abrupt cessation of reboxetine along alcohol deprivation results in alcohol intake escalation after reinstatement of drinking. Addict Biol, 26(3):e12957. IF: 4.28 Ranking:Q1

  • Sayd A, Vargas-Caraveo A, Perea-Romero I, Robledo-Montaña J, Caso JR, Madrigal JLM, Leza JC, Orio L, Garcia-Bueno B. (2020). Depletion of  brain perivascular macrophages regulates acute restraint stress-induced neuroinflammation and oxidative/nitrosative stress in rat frontal cortex. European Neuropsychopharmacology 34, 50-64 

    IF: 4.60 Ranking: Q1

  • Rodriguez-Gonzalez A, Orio L* (2020). Microbiota and alcohol use disorder: are psychobiotics a novel therapeutic strategy? Current Pharmaceutical Design 

    *corresponding author. IF: 3.12 
  • Orio, L.* (2020) The multifaceted potential of the lipid transmitter oleoylethanolamide to treat alcohol-induced neuroinflammation and alcohol use disorders. Neural Regeneration Research 15(1):71-72. *corresponding author. IF: 5.14. Ranking: Q2
  • Orio L*, Alen F, Javier Pavon F, Serrano A, Garcia-Bueno B (2019) Oleoylethanolamide, Neuroinflammation, and Alcohol Abuse. Frontiers in Molecular Neuroscience 11. *corresponding author. IF: 4.057. Ranking: Q2   

  • Anton M, Rodriguez-Gonzalez A, Ballesta A, Gonzalez N, del Pozo A, de Fonseca FR, Gomez-Lus ML, Leza JC, Garcia-Bueno B, Caso JR, Orio L*

    (2018) Alcohol binge disrupts the rat intestinal barrier: the partial protective role of oleoylethanolamide. British Journal of Pharmacology 175:4464-4479.  *corresponding author.  

    IF: 6.583. Ranking: Q1 (D1)

  • Anton M, Rodriguez-Gonzalez A, Rodriguez-Rojo IC, Pastor A, Correas A, Serrano A, Ballesta A, Alen F, Gomez de Heras R, de la Torre R, Rodriguez de Fonseca F, Orio L* (2018) Increased plasma oleoylethanolamide and palmitoleoylethanolamide levels correlate with inflammatory changes in alcohol binge drinkers: the case of HMGB1 in women. Addiction Biology 23:1242-1250. *corresponding author. 

    IF: 4.223. Ranking: Q1

  • Orio L*, Anton M, Rodriguez-Rojo IC, Correas A, Garcia-Bueno B, Corral M, de Fonseca FR, Garcia-Moreno LM, Maestu F, Cadaveira F (2018) Young alcohol binge drinkers have elevated blood endotoxin, peripheral inflammation and low cortisol levels: neuropsychological correlations in women Addiction Biology 23(5): 1130-1144. *corresponding author. 

    IF: 4.223. Ranking: Q1

  • Garcia-Marchena N, Pavon FJ, Pastor A, Araos P, Pedraz M, Romero-Sanchiz P, Calado M, Suarez J, Castilla-Ortega E, Orio L, Boronat A, Torrens M, Rubio G, de la Torre R, Rodriguez de Fonseca F, Serrano A (2017) Plasma concentrations of oleoylethanolamide and other acylethanolamides are altered in alcohol-dependent patients: effect of length of abstinence. Addiction Biology 22(5):1366-1377. 

    IF: 3.947 . Ranking: Q1

  • Anton M, Alen F, Gomez de Heras R, Serrano A, Javier Pavon F, Carlos Leza J, Garcia-Bueno B, Rodriguez de Fonseca F, Orio L* (2017) Oleoylethanolamide prevents neuroimmune HMGB1/TLR4/NF-kB danger signaling in rat frontal cortex and depressive-like behavior induced by ethanol binge administration. Addiction Biology 22(3):724-741. *corresponding author. 

     

    IF: 3.947. Ranking: Q1

  • Bilbao A, Serrano A, Cippitelli A, Pavon FJ, Giuffrida A, Suarez J, Garcia-Marchena N, Baixeras E, Gomez de Heras R, Orio L, Alen F, Ciccocioppo R, Cravatt BF, Parsons LH, Piomelli D, Rodriguez de Fonseca F (2016) Role of the satiety factor oleoylethanolamide in alcoholism. Addiction Biology 21(4):859-872. 

    IF: 3.332. Ranking: Q1

  • Sayd A, Anton M, Alen F, Caso JR, Pavon J, Leza JC, de Fonseca RF, Garcia-Bueno B, Orio L* (2015) Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats International Journal of Neuropsychopharmacology 18(6) pii:pyu111. *corresponding author. 

    IF: 4.333. Ranking: Q1

IN THE FIELD OF PSYCHOPHARMACOLOGY AND DRUGS OF ABUSE

  • Orio L, Javier Pavon F, Blanco E, Serrano A, Araos P, Pedraz M, Rivera P, Calado M, Suarez J, Rodriguez de Fonseca F (2013) Lipid Transmitter Signaling as a New Target for Treatment of Cocaine Addiction: New Roles for Acylethanolamides and Lysophosphatidic Acid. Current Pharmaceutical Design 19(40):7036-7049.

      

    IF: 3.288. Ranking: Q1

  • Alen F#/Orio L#, Gorriti MA, Gomez de Heras R, Teresa Ramirez-Lopez M, Angel Pozo M, Rodriguez de Fonseca F (2013) Increased alcohol consumption in rats after subchronic antidepressant treatment. International Journal of Neuropsychopharmacology 16(8):1809-1818. #equal contribution

     IF: 5.26  Ranking: Q1 (D1)

  • Orio L*, Wee S, Newman AH, Pulvirenti L, Koob GF (2010) The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access. Addiction Biology 15(3):312-323. *corresponding author

      

    IF: 4.152 Ranking: Q1 (D1)

  • Orio L*, Edwards S, George O, Parsons LH, Koob GF (2009) A Role for the Endocannabinoid System in the Increased Motivation for Cocaine in Extended-Access Conditions. Journal of Neuroscience 29(15):4846-4857.   *corresponding author 

    IF: 7.178  Ranking: Q1 (D1) 

BOOK CHAPTERS IN: